Medicare Enrolled
Dr. Harry Saperstein, M.D.
Procedural Dermatology Physician · Beverly Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saperstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saperstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saperstein
Dr. Harry Saperstein is a procedural dermatology physician in Beverly Hills, CA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Saperstein performed 35,322 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Saperstein received a total of $8,604 from 48 pharmaceutical and/or device companies across 411 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saperstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 2% volume in CA
$8,604 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗35,322
Medicare services
Top 2% in CA for procedural dermatology physician
Not available
Unique patients (not deduplicated)
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
14,024 | $6 | $13 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
5,320 | $32 | $52 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
4,218 | $71 | $111 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
2,505 | $70 | $131 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
2,356 | $34 | $95 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
2,177 | $47 | $76 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
1,792 | $102 | $139 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
640 | $148 | $206 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
333 | $1 | $5 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
235 | $82 | $145 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $50 | $71 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
201 | $32 | $73 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
167 | $426 | $588 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
156 | $384 | $516 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
136 | $129 | $327 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
113 | $53 | $127 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
111 | $117 | $296 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
99 | $133 | $332 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
90 | $357 | $490 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
65 | $186 | $250 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
51 | $164 | $310 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
47 | $10 | $34 |
| Skin cancer removal, face/ears/eyes/nose/lips, 2.1-3.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 2.1 and 3.0 centimeters. |
42 | $147 | $375 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $112 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $12 | $30 |
| Complex repair of eyelid, nose, ear, or lip wound, 2.6-7.5 cm A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 2.6 and 7.5 centimeters. |
28 | $450 | $602 |
| Surgical removal of skin cancer, 2.1-3.0 cm Surgical excision of a cancerous skin growth measuring 2.1 to 3.0 centimeters from the scalp, neck, hands, feet, or genitals. |
20 | $168 | $354 |
| Destruction of eyelid margin growth, 1.0 cm or less This procedure involves the removal or destruction of a growth located on the margin of the eyelid that measures 1.0 centimeter or smaller. |
20 | $196 | $265 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
19 | $124 | $220 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
17 | $102 | $150 |
| Removal of noncancer skin growth, 2.1-3.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The excised tissue measures between 2.1 and 3.0 centimeters in diameter. |
16 | $79 | $238 |
| Surgical removal of skin cancer, 3.1-4.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue is between 3.1 and 4.0 centimeters. |
16 | $141 | $368 |
| Complicated wound repair, each additional 5 cm or less This code covers the additional work for a complex surgical repair of a wound on the scalp, arms, or legs when the repair extends beyond the initial measurement. It is billed for each incremental 5-centimeter segment added to the primary procedure. |
16 | $115 | $165 |
| Skin graft repair, 10 sq cm or less A surgical procedure to repair a wound by transferring a small piece of skin to the affected area. The graft covers wounds on the face, neck, hands, feet, or other specified body parts. |
16 | $674 | $865 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 12 | $151 | $223 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,604
Total received (2018-2024)
Avg $1,229/year across 7 years
Top 26% in CA for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
411
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,856
2023
$1,976
2022
$1,139
2021
$588
2020
$696
2019
$1,134
2018
$1,216
Payments by company (2024)
GENZYME CORPORATION
$468
E.R. Squibb & Sons, L.L.C.
$270
ABBVIE INC.
$237
Janssen Biotech, Inc.
$134
Regeneron Healthcare Solutions, Inc.
$114
Amgen Inc.
$76
Incyte Corporation
$72
SUN PHARMACEUTICAL INDUSTRIES INC.
$71
Dermavant Sciences, Inc.
$71
Galderma Laboratories, L.P.
$65
Arcutis Biotherapeutics, Inc.
$55
PFIZER INC.
$49
LEO Pharma Inc.
$45
Lilly USA, LLC
$39
UCB, Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
MAYNE PHARMA COMMERCIAL LLC
$19
Ortho Dermatologics, a division of Bausch Health US, LLC
$17
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$1,077
Galderma Laboratories, L.P.
$674
Regeneron Healthcare Solutions, Inc.
$614
Amgen Inc.
$504
Janssen Biotech, Inc.
$406
LEO Pharma Inc.
$399
E.R. Squibb & Sons, L.L.C.
$365
Merz North America, Inc.
$356
Novartis Pharmaceuticals Corporation
$350
ABBVIE INC.
$345
PFIZER INC.
$335
AbbVie Inc.
$328
EPI Health, LLC
$241
Lilly USA, LLC
$215
Allergan Inc.
$207
Dermavant Sciences, Inc.
$199
MERZ NORTH AMERICA, INC.
$183
Ortho Dermatologics, a division of Bausch Health US, LLC
$181
Incyte Corporation
$160
Mayne Pharma Inc.
$141
Glenmark Therapeutics Inc.
$132
Arcutis Biotherapeutics, Inc.
$121
Exeltis, USA Inc.
$76
Celgene Corporation
$71
SUN PHARMACEUTICAL INDUSTRIES INC.
$71
Sun Pharmaceutical Industries Inc.
$69
AbbVie, Inc.
$68
UCB, Inc.
$63
MAYNE PHARMA INC.
$57
VYNE Pharmaceuticals Inc.
$52
Allergan, Inc.
$52
Journey Medical Corporation
$44
Bayer HealthCare Pharmaceuticals Inc.
$43
Sandoz Inc.
$41
MAYNE PHARMA COMMERCIAL LLC
$38
Pierre Fabre Pharmaceuticals, Inc.
$36
Almirall LLC
$34
Encore Dermatology Inc.
$33
Krystal Biotech Inc
$29
Mission Pharmacal Company
$29
Medimetriks Pharmaceuticals, Inc.
$27
SANOFI-AVENTIS U.S. LLC
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Helsinn Therapeutics (U.S.), Inc.
$20
Genentech USA, Inc.
$19
Promius Pharma LLC
$19
Aclaris Therapeutics, Inc.
$15
PruGen, Inc. Pharmaceuticals
$15
Top 3 companies account for 27.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · ALTRENO · AMZEEQ · Avar · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Exelderm · FINACEA · Finacea · Genadur · HUMIRA · Humira · ILUMYA · Impoyz · JUBLIA · KERYDIN · LIBTAYO · Mupirocin Cream · Neo-Synalar Cream Kit · OPZELURA · ORACEA · Odomzo · Otezla · PICATO · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo Spray · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TargaDox · Tremfya · VALCHLOR · VTAMA · VYJUVEK · Veltin · Winlevi · Xolair · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Procedural dermatology physicians in nearby ZIP areas
29
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saperstein is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saperstein experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Saperstein performed 14,024 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Saperstein receive payments from pharmaceutical companies?
Yes. Dr. Saperstein received a total of $8,604 from 48 companies across 411 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saperstein's costs compare to other procedural dermatology physicians in Beverly Hills?
Dr. Saperstein's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saperstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Procedural Dermatology Physicians in Beverly Hills
Browse procedural dermatology physicians in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Procedural Dermatology Physicians in CA
Procedural dermatology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Procedural Dermatology Physicians in CA
Which CA procedural dermatology physicians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology